Medication info
Youngjin Aspirin Enteric-coated Tablet

Youngjin Aspirin Enteric-coated Tablet

OTC medicationTabletOral
Ingredient · strength
Aspirin›100mg / 1 tablet
Manufacturer / importer
Youngjin Pharmaceutical Co., Ltd.
Appearance
White enteric-coated tablet
Packaging
300 tablets/bottle
Approval status
Active

MFDS item code 200200734 · Notified 2002.08.01 · Insurance code 642400970

Summary

Main use
Prevention of blood clots (e.g., after myocardial infarction or coronary intervention); reduction of cardiovascular risk in high-risk patients
Who takes it
Adults
Adult dose
(Enteric-coated tablets) Adults: 1 tablet once daily. Do not take a high dose without a doctor's prescription. In general, aspirin-containing products should not be taken on an empty stomach due to the adverse reaction of gastrointestinal bleeding; however, because this product is enteric-coated, it may be taken before meals with plenty of water. Because of the risk of bleeding, inform and consult the attending physician that you are taking an aspirin product if undergoing surgery (including dental surgery). (Enteric-coated capsules) Adults: 1 capsule once daily. Do not take a high dose without a doctor's prescription. In general, aspirin-containing products should not be taken on an empty stomach due to the adverse reaction of gastrointestinal bleeding; however, because this product is enteric-coated, it may be taken before meals with plenty of water. Because of the risk of bleeding, inform and consult the attending physician that you are taking an aspirin product if undergoing surgery (including dental surgery).

Ingredients

Manufacturer
Youngjin Pharmaceutical Co., Ltd.

Efficacy & effects

Prevention of blood clots (e.g., after myocardial infarction or coronary intervention); reduction of cardiovascular risk in high-risk patients

  • Myocardial infarction
  • cerebral infarction
  • unstable angina
View approved original text

This drug inhibits thrombus formation in major cardiovascular diseases such as myocardial infarction, cerebral infarction, and unstable angina, helping to maintain blood flow. It also contributes to the prevention of complications by inhibiting thrombus formation after coronary artery bypass grafting or percutaneous coronary intervention. It effectively reduces cardiovascular risk in high-risk patients, such as those with a family history of ischemic heart disease or multiple risk factors like hypertension, hypercholesterolemia, obesity, and diabetes. This drug is effective in the prevention and treatment of thrombus-related cardiovascular diseases.

How to take

Adult dose

(Enteric-coated tablets) Adults: 1 tablet once daily. Do not take a high dose without a doctor's prescription. In general, aspirin-containing products should not be taken on an empty stomach due to the adverse reaction of gastrointestinal bleeding; however, because this product is enteric-coated, it may be taken before meals with plenty of water. Because of the risk of bleeding, inform and consult the attending physician that you are taking an aspirin product if undergoing surgery (including dental surgery). (Enteric-coated capsules) Adults: 1 capsule once daily. Do not take a high dose without a doctor's prescription. In general, aspirin-containing products should not be taken on an empty stomach due to the adverse reaction of gastrointestinal bleeding; however, because this product is enteric-coated, it may be taken before meals with plenty of water. Because of the risk of bleeding, inform and consult the attending physician that you are taking an aspirin product if undergoing surgery (including dental surgery).

Precautions

Individuals who regularly consume three or more drinks of alcohol per day should consult a doctor or pharmacist before taking this medication, as there is a risk of gastrointestinal bleeding associated with this drug. This drug is contraindicated in certain patients. For example, individuals allergic to this drug or other salicylates, patients with peptic ulcers, aspirin-induced asthma, hemophilia, those with severe liver or kidney dysfunction, severe heart failure, those with bleeding tendencies, patients currently taking high doses of methotrexate, and pregnant women in their third trimester should not take this medication. Additionally, those with kidney or liver dysfunction, cardiovascular diseases, blood disorders, bronchial asthma, patients prior to surgery, children under 3 years, patients with a history of allergies, the elderly, those on anticoagulants, and patients with glucose-6-phosphate dehydrogenase deficiency should use this drug with caution. Particularly, patients with G6PD deficiency are at risk for hemolytic anemia, so caution is required. During the use of this drug, symptoms such as shock, anaphylaxis, hypersensitivity, skin rashes, blood disorders, gastrointestinal symptoms (such as abdominal pain and vomiting), neurological symptoms (such as dizziness and headaches), liver impairment, and kidney impairment may occur. If any abnormal symptoms appear, discontinue use immediately and seek medical attention. In children under 14 years with chickenpox or influenza, this drug should be administered with caution, and their condition should be closely monitored after administration. When used for chronic or acute conditions, regular examinations should be conducted to identify adverse reactions, and dosage adjustments or discontinuation should be considered as necessary. This drug may increase the risk of bleeding by inhibiting platelet aggregation, so extra caution is needed before and after surgery, and if bleeding symptoms arise, consultation with a physician is essential. This drug may interact with other medications, particularly anticoagulants, thrombolytics, diabetes treatments, non-steroidal anti-inflammatory drugs such as ibuprofen, methotrexate, lithium, and selective serotonin reuptake inhibitors (SSRIs), so consultation with a healthcare professional is necessary. During pregnancy, especially in the third trimester, this drug should not be taken; in the first and second trimesters, it should only be used if absolutely necessary, limited to the minimum dosage and duration. Breastfeeding women are also advised against using this drug. The elderly may experience adverse reactions more easily, so they should start with a low dose and monitor their condition closely during use. This drug comes in an enteric-coated form, so care should be taken not to damage the enteric coating, and it is advisable not to take it with certain alkalizing agents. Lastly, this drug should be stored out of reach of children, kept in its original container, and transferring it to another container may pose risks of degradation or misuse.

Side effects

Gastrointestinal bleeding, shock, anaphylactic symptoms, dyspnea, generalized flushing, angioedema, urticaria, asthma attack, erythema, pruritus, nasal congestion, cardiac-respiratory disorders, rash, edema, rhinitis-like symptoms, conjunctivitis, Reiter's syndrome, drug reactions with eosinophilia and systemic symptoms, Stevens-Johnson syndrome, exfoliative dermatitis, aplastic anemia, anemia, leukopenia, thrombocytopenia, impaired platelet function, hemolysis, hemolytic anemia, loss of appetite, heartburn, abdominal pain, nausea, vomiting, tinnitus, hearing loss, dizziness, headache, agitation, liver dysfunction, elevated liver transaminases, liver damage, kidney dysfunction, acute renal failure, hyperventilation, metabolic acidosis, bleeding, hematoma, epistaxis, genitourinary bleeding, gum bleeding, cerebral hemorrhage, hallucinations, seizures, coma, respiratory paralysis, circulatory disorders

Not everyone experiences these, and they can vary from person to person.

Interactions

Drug interactions

This drug may increase the risk of bleeding or decrease renal function when used in combination with other non-steroidal anti-inflammatory drugs and salicylate preparations. Do not use in combination with methotrexate at doses of 15 mg or more for one week. Additionally, certain non-steroidal anti-inflammatory drugs such as anticoagulants, ibuprofen, naproxen, thrombolytics, other platelet aggregation inhibitors, hemostats, diabetes treatments, uricosurics, and thiazide diuretics may interact with this drug.

Storage

This drug should be stored in a tightly sealed container to prevent air exposure, and the temperature should be kept between 15 and 25 degrees Celsius. Keeping it in this way will help maintain the drug's efficacy for a longer duration.

Appearance and packaging

Appearance

White enteric-coated tablet

Package unit

300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.